Drug Database
Back to search

Finland· FI-REL-REL47295

Konakion Novum

A phytomenadione product containing phytomenadione, registered in Finland by Paranova Oy. The same ATC class is registered in 15 of our 19 countries.

ATC B02BA01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedKonakion NovumATCB02BA01REGISTER NO.FI-REL-REL47295PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about phytomenadioneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Phytomenadione is registered in 15 of 19 countries.

Countries holding a registration under ATC B02BA01 (phytomenadione), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 8 of them publish a price we can compare per daily dose
Search phytomenadione products by name

Phytomenadione · ATC B02BA01

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Phytomenadione
Manufacturer
Paranova Oy
Country
Finland (FI)
ATC code
B02BA01
ATC class
Phytomenadione
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

188 interactions on record for phytomenadione.

Graded by severity as the source publishes them — 6 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check phytomenadione against other medicinesHow interaction checks work

Phytomenadione · interactions on record

188 records

  • 6 moderate
  • 2 minor
  • 180 info

Most severe, free to view

  • DicoumarolB01AA01moderate
  • WarfarinB01AA03moderate
  • ColestyramineC10AC01moderate
  • ColestipolC10AC02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Phytomenadione in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All phytomenadione products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Konakion
  • Belgium · Konakion, Konakion Paediatric
  • Cyprus · Kanavit
  • Czechia · Kanavit
  • Germany · Ka-Vit Tropfen, Konakion
  • Denmark · Konakion Novum, Menadion Scanpharm
  • Spain · Konakion, Konakion Pediátrico
  • France · Vitamine K1 Cheplapharm, Vitamine K1 Nourrissons Cheplapharm
  • United Kingdom (Northern Ireland) · Konakion Mm Ampoules, Konakion Mm Paediatric
  • Croatia · Konakion Mm
  • Hungary · Konakion
  • Ireland · Konakion Mm Ampoules, Konakion Mm Paediatric Ampoules
  • Italy · Konakion, Konakion Prima Infanzia
  • Malta · Konakion Mm Ampoules, Konakion Mm Paediatric Ampoules
  • Netherlands · Konakion Mixed Micelles, Konakion Mm Voor Kinderen
  • Norway · Konakion
  • Poland · Phytomenadione Bb Pharma, Vitacon
  • Portugal · Kanakion Mm, Kanakion Mm Pediátrico
  • Romania · Fitomenadion Terapia
  • Sweden · Konakion
  • Slovakia · Kanavit

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/14b92b36-916a-48a0-907d-3fca9d654a3a
GET /v1/drugs/14b92b36-916a-48a0-907d-3fca9d654a3a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "20",
  "form": "injektioneste, liuos",
  "route": "Suun kautta",
  "ddd_unit": "mg",
  "strength": "10 mg/ml",
  "atc_label": "fytomenadioni",
  "ma_number": "33271",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL47295",
  "authorised_at": "2015-09-07"
}
API referenceMCP serverPlans

See everything about phytomenadione.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console